ID | 65991 |
フルテキストURL | |
著者 |
Tomita, Koji
Department of Radiology, Okayama University Hospital
Matsui, Yusuke
Department of Radiology, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
Uka, Mayu
Department of Radiology, Okayama University Hospital
Umakoshi, Noriyuki
Department of Radiology, Okayama University Hospital
Kawabata, Takahiro
Department of Radiology, Okayama University Hospital
Munetomo, Kazuaki
Department of Radiology, Okayama University Hospital
Nagata, Shoma
Department of Radiology, Okayama University Hospital
Iguchi, Toshihiro
Department of Radiological Technology, Faculty of Health Sciences, Okayama University
Kaken ID
Hiraki, Takao
Department of Radiology, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
Kaken ID
publons
researchmap
|
抄録 | Purpose This review aimed to summarize the treatment outcomes of percutaneous radiofrequency ablation (RFA) and microwave ablation (MWA) for metastatic liver tumors based on the findings of published studies over the last decade.
Materials and methods Literature describing the survival outcomes of ablation therapy for liver metastases was explored using the PubMed database on April 26, 2022, and articles published in 2012 or later were selected. The included studies met the following criteria: (i) English literature, (ii) original clinical studies, and (iii) literature describing overall survival (OS) of thermal ablation for metastatic liver tumors. All case reports and cohort studies with fewer than 20 patients and those that evaluated ablation for palliative purposes were excluded. Results RFA was the most commonly used method for ablation, while MWA was used in several recent studies. RFA and MWA for liver metastases from various primary tumors have been reported; however, majority of the studies focused on colorectal cancer. The local control rate by RFA and MWA varied widely among the studies, ranging approximately 50–90%. Five-year survival rates of 20–60% have been reported following ablation for colorectal liver metastases by a number of studies, and several reports of 10-year survival rates were also noted. Conclusion Comparative studies of local therapies for colorectal liver metastases demonstrated that RFA provides comparable survival outcomes to surgical metastasectomy and stereotactic body radiation therapy. |
キーワード | Ablation
Liver
Metastasis
|
備考 | The version of record of this article, first published in Japanese Journal of Radiology, is available online at Publisher’s website: http://dx.doi.org/10.1007/s11604-022-01335-5
|
発行日 | 2022-09-13
|
出版物タイトル |
Japanese Journal of Radiology
|
巻 | 40巻
|
号 | 10号
|
出版者 | Springer Science and Business Media LLC
|
開始ページ | 1035
|
終了ページ | 1045
|
ISSN | 1867-1071
|
資料タイプ |
学術雑誌論文
|
言語 |
英語
|
OAI-PMH Set |
岡山大学
|
著作権者 | © The Author(s) 2022
|
論文のバージョン | publisher
|
PubMed ID | |
DOI | |
Web of Science KeyUT | |
関連URL | isVersionOf https://doi.org/10.1007/s11604-022-01335-5
|
ライセンス | http://creativecommons.org/licenses/by/4.0/
|
Citation | Tomita, K., Matsui, Y., Uka, M. et al. Evidence on percutaneous radiofrequency and microwave ablation for liver metastases over the last decade. Jpn J Radiol 40, 1035–1045 (2022). https://doi.org/10.1007/s11604-022-01335-5
|